LobbyingSpring Care lobbying by quarter
Spring Care's latest lobbying report covers Q2 2026, at $38K. Its first report covers Q1 2026; the issues it reports most are Budget/Appropriations and Health Issues.
Spring Care
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $65.5K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $27.5K | 2 |
| Q2 2026 | $38K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$11.8K · 2 reports
- Health issues$11.8K · 2 reports
- Science and technology$11.8K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Food & Drug Administration (FDA)1 reports
- Natl Institute of Standards & Technology (NIST)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSpring Care | $35.5K | 2 quarters |
| Leavitt Partners | $30K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Leavitt Partners | $20K |
| 07/14for Q2 | In-house | $18K |
| 04/20for Q1 | Leavitt Partners | $10K |
| 04/20for Q1 | In-house | $17.5K |
| 01/16for Q1 | Leavitt Partners | Under $5,000 |
| 01/13for Q1 | In-house | Under $5,000 |